🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

203+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 203 recruiting trials for “combined-hepatocellular-carcinoma-and-cholangiocarcinoma

Phase 1RecruitingNCT04823403

Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma

🏥 Gustave Roussy, Cancer Campus, Grand Paris📍 1 site📅 Started Nov 2020View details ↗
Phase 2RecruitingNCT04770207

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

👨‍⚕️ Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Nov 2020View details ↗
NARecruitingNCT06487663

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

🏥 Tianjin Medical University Cancer Institute and Hospital📍 1 site📅 Started Oct 2020View details ↗
RecruitingNCT04340986

Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma

👨‍⚕️ Marie LEQUOY, MD, AssistancePublique-Hôpitaux de Paris📍 1 site📅 Started Sep 2020View details ↗
Enrolling by InvitationNCT04572711

Prospective Evaluation of Biliary Tissue Sampling with ERCP

👨‍⚕️ Vinay Chandrasekhara, MD, Mayo Clinic📍 1 site📅 Started Sep 2020View details ↗
RecruitingNCT04390724

Optimizing Y90 Therapy for Radiation Lobectomy

👨‍⚕️ Robert Lewandowski, MD, Northwestern University📍 2 sites📅 Started Jul 2020View details ↗
RecruitingNCT05520788

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

👨‍⚕️ Wanguang Zhang, Tongji Hospital📍 1 site📅 Started May 2020View details ↗
Phase 1RecruitingNCT04248569

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

👨‍⚕️ Mark Yarchoan, MD, Johns Hopkins Medical Institution📍 1 site📅 Started Apr 2020View details ↗
RecruitingNCT04525833

Liver Disease and Other Systemic Diseases

👨‍⚕️ Ching-Sheng Hsu, Ph.D, Liver Diseases Research Center, Taipei Tzu Chi Hospital📍 1 site📅 Started Jan 2020View details ↗
NARecruitingNCT04078230

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 13 sites📅 Started Jan 2020View details ↗
Phase 1, PHASE2RecruitingNCT03942328

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

👨‍⚕️ Lewis R. Roberts, MD, PhD, Mayo Clinic in Rochester📍 1 site📅 Started Sep 2019View details ↗
RecruitingNCT03894917

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

👨‍⚕️ Sukeshi Patel Arora, MD, Mays Cancer Center📍 1 site📅 Started Sep 2019View details ↗
NARecruitingNCT04037007

Efficacy of Fistulotomy for Biliary Cannulation

👨‍⚕️ Oscar V Hernandez Mondragon, MD, Instituto Mexicano del Seguro Social📍 1 site📅 Started Jul 2019View details ↗
NARecruitingNCT07305428

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

🏥 The University of Hong Kong📍 1 site📅 Started Apr 2019View details ↗
NARecruitingNCT03823144

Intravital Microscopy in Human Solid Tumors

👨‍⚕️ Emmanuel M Gabriel, M.D., Ph.D., Mayo Clinic📍 1 site📅 Started Feb 2019View details ↗
RecruitingNCT05276037

Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates

🏥 University of Liege📍 6 sites📅 Started Jan 2019View details ↗
RecruitingNCT03612726

The Overall Survival of Patients With Unresectable HCC in Real-life

👨‍⚕️ Masao Omata, PhD, MD, Tokyo University📍 3 sites📅 Started Jul 2018View details ↗
RecruitingNCT03637569

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

🏥 Samsung Medical Center📍 1 site📅 Started Apr 2018View details ↗
Enrolling by InvitationNCT07042841

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

👨‍⚕️ Shuo Jin, PhD, Beijing Tsinghua Chang Gung Hospital📍 1 site📅 Started Jun 2015View details ↗
RecruitingNCT03959800

Molecular Basis of Pediatric Liver Cancer

🏥 University of Pittsburgh📍 1 site📅 Started Jun 2015View details ↗
← PreviousPage 10 of 11Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →